Jeanette Winterling
About me
I work as a head of the Psychooncology unit for adult cancer patients and the survivorship unit for adults that had cancer as a child at the
Comprehensive Cancer Centre (Theme Cancer) at the Karolinska Comprehensiv Cancer Centre at Karolinska University Hospital in Stockholm.As a researcher I am conected to Yvonne Wengströms research group at Karolinska Institutet.
Education:
Registred Nurse 1997
Basic education in Psychoterapy 2000
Magister in Caring Science 2002
PhD in Caring Science 2007Associate professor in Caring Sience 2023
Research
My research has consistently focused on psychosocial aspects of patients and relatives with cancer.
I finished my PhD in 2007 at Uppsala University with the thesis "Hope and Despair - Philosophy of life, expectations and optimism in cancer patient and their spouses”. The thesis involved life situation, philosophy of life, optimism and bereavement in patients with gastrointestinal cancer in a palliative phase, and their spouses, as well as on cancer patients' expectations on the time coming after they finished a curative cancer treatment. I did a postdoc in the Fex-Can research project which included to examine different aspects of children, teens and young adults' situation during and after cancer, such as life situation, school situation, sexuality and fertility.
My research has evolved from primarily focusing on understanding patients’ and family members’ symptoms, life situations, and quality of life during and after cancer treatment, to also encompassing the development, implementation, and evaluation of interventions and care models. In 2026, I am the PI for the following research projects:
• The Frailty Project – investigating the use of the Edmonton Frail Scale as a screening tool among elderly (>65 years of age) lung cancer patients at the Karolinska Comprehensive Cancer Centre. Started in 2021.
• The MyCode Project – adapting, implementing, and evaluating a psychosocial support model for young adult cancer patients (16–30 years of age), including Team Young and the PRISM intervention, at the Karolinska and Sahlgrenska Comprehensive Cancer Centres. Started in 2020.
• The Swedish PanCare4AYA Project – evaluating a long‑term follow‑up program at the Karolinska Comprehensive Cancer Centre for patients diagnosed with cancer between 16 and 30 years of age who are now more than 5 years post‑diagnosis. This work is part of a larger EU initiative. Started in 2025.
• The CAR‑T‑Cell Project – exploring patients’ experiences related to CAR‑T‑cell therapy, with a focus on quality of life, symptoms, patient participation, and the experience of receiving treatment at home. Started in 2024.
Being co-PI for:
• The ELEVATE Project – exploring the use of a conversational tool to support communication between patients and nurses in hematological care at the Karolinska and Skåne Comprehensive Cancer Centres. Started in 2025.
Ended projects:
- The aCent research project - It is about developing, implementing and evaluation a model for person-centred care for patients and family caregivers in the context of allogenic stem cell transplantation.
- The Donor research project - It is about investigationd the psychological well being of donors in allogenic stem cell transplantation.
Teaching
I am course coordinator for the course Rehabilitation within cancer care, 7.5 hp at Karolinska Institutet and are involved in other courses at Karolinska as well as other Universities.
Articles
- Journal article: SCANDINAVIAN JOURNAL OF CARING SCIENCES. 2025;39(4):e70153Engberg de Carvalho C; O'Sullivan A; Bergkvist K; Lundh Hagelin C; Winterling J; Malmborg Kisch A
- Journal article: JAMA NETWORK OPEN. 2025;8(12):e2549071Sodergren SC; Husson O; Janssen S; Rohde GE; Hossain MJ; Abaza H; Alkan A; Al-Omari A; Ben-Aharon I; Bentsen L; Guren MG; Ioannidis G; Ishiki H; Koehler M; Lidington E; Lugowska I; McDonald F; Krishnamurthy MN; Korenblum C; Majorana A; Memos N; Otth M; Pappot H; Perez-Campdepadros M; Petranovic D; Richter D; Roganovic J; Scheinemann K; Sikora-Koperska A; Stark D; Stavrou N; Turhal S; Winterling J; Yarom N; Darlington A-SE
- Article: HEALTH AND QUALITY OF LIFE OUTCOMES. 2025;23(1):111Mollerstrand A; Winterling J; Kottorp A; Jervaeus A
- Journal article: HEALTHCARE. 2025;13(19):2463Kisch AM; Eriksson LV; O'Sullivan A; Shahriari A; Bergkvist K; Hagelin CL; Winterling J
- Journal article: ANNALS OF ONCOLOGY. 2025;36:s1649-S1538Dahlen C; Ullgren H; Frankling MH; Winterling J
- Journal article: JOURNAL OF CLINICAL APHERESIS. 2025;40(4):e70050Kisch AM; Winterling J; Hagglund H; Larfors G; Lenhoff S; Pahnke S
- Article: JOURNAL OF PSYCHOSOCIAL ONCOLOGY. 2025;43(4):513-529Odling M; Jervaeus A; Wengstrom Y; Rosenberg AR; Yi-Frazier JP; Winterling J
- Article: CLINICAL NURSING RESEARCH. 2025;34(2):86-94O'Sullivan A; Hagelin CL; Holmberg K; Bergkvist K; Bala S-V; Wengstrom Y; Kisch AM; Winterling J
- Article: HEALTH SERVICES INSIGHTS. 2025;18:11786329241310735O'Sullivan A; Winterling J; Kisch AM; Bergkvist K; Edvardsson D; Wengstrom Y; Hagelin CL
- Article: TRANSPLANTATION PROCEEDINGS. 2023;55(1):242-248Winterling J; Pahnke S; Lagnebjork J; Hagglund H; Larfors G; Lenhoff S; Kisch AM
- Article: CANCER NURSING. 2023;46(1):77-85Eriksson LV; Holmberg K; Lundh Hagelin C; Wengstrom Y; Bergkvist K; Winterling J
- Article: SUPPORTIVE CARE IN CANCER. 2022;30(11):9039-9047Kisch AM; Bergkvist K; Adalsteinsdottir S; Wendt C; Alvariza A; Winterling J
- Journal article: ANNALS OF ONCOLOGY. 2022;33:s1202Winterling J; Pahnke S; Hägglund H; Larfors G; Lennhof S; Kisch A
- Article: PALLIATIVE & SUPPORTIVE CARE. 2022;20(4):519-526Winterling J; Kisch A; Alvariza A; Arestedt K; Bergkvist K
- Journal article: JOURNAL OF PSYCHOSOCIAL ONCOLOGY RESEARCH AND PRACTICE. 2022;4(3)Winterling J; Wengstrom Y
- Article: PSYCHO-ONCOLOGY. 2022;31(1):46-53Cheli S; Lam WWT; Estape T; Winterling J; Bahcivan O; Andritsch E; Weis J; Centeno I; Serpentini S; Farkas C; Wengstrom Y; Fioretto L; Baider L; Lam CCL; Goldzweig G
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2021;15(6):933-941Eriksson L; Wennman-Larsen A; Bergkvist K; Ljungman P; Winterling J
- Article: BMC HEALTH SERVICES RESEARCH. 2021;21(1):933Winterling J; Delilovic S; Dervish J; Gunarsson M; Ahstrom M; Hasson H
- Article: SUPPORTIVE CARE IN CANCER. 2021;29(6):3347-3356Kisch AM; Bergkvist K; Alvariza A; Arestedt K; Winterling J
- Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2020;46:101740Bergkvist K; Winterling J; Kisch AM
- Article: JOURNAL OF CANCER EDUCATION. 2020;35(3):538-544Winterling J; Lampi C; Wettergren L
- Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2020;44:101710Nilsson J; Roing M; Malmros J; Winterling J
- Article: EUROPEAN JOURNAL OF CANCER CARE. 2018;27(2):e12808Winterling J; Johansson E; Wettergren L; Ljungman P; Alexanderson K
- Article: SUPPORTIVE CARE IN CANCER. 2017;25(12):3675-3682Wiklander M; Strandquist J; Obol CM; Eriksson LE; Winterling J; Rodriguez-Wallberg KA; Fugl-Meyer KS; Ahlgren J; Ljungman P; Lampic C; Wettergren L
- Article: JMIR RESEARCH PROTOCOLS. 2016;5(2):e60Winterling J; Wiklander M; Obol CM; Lampic C; Eriksson LE; Pelters B; Wettergren L
- Article: JOURNAL OF PEDIATRIC ONCOLOGY NURSING. 2015;32(4):201-208Winterling J; Jervaeus A; Af Sandeberg M; Johansson E; Wettergren L
- Article: SUPPORTIVE CARE IN CANCER. 2015;23(5):1273-1283Bergkvist K; Winterling J; Johansson E; Johansson U-B; Svahn B-M; Remberger M; Mattsson J; Larsen J
- Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2015;19(2):99-106Ryblom H; Hast R; Hellstrom-Lindberg E; Winterling J; Johansson E
- Article: BONE MARROW TRANSPLANTATION. 2014;49(6):836-842Winterling J; Johansson E; Wennman-Larsen A; Petersson L-M; Ljungman P; Alexanderson K
- Article: CANCER NURSING. 2013;36(5):400-407Doukkali EB; Winterling J; Eriksson LE; Lampic C; Hagstrom AS; Wettergren L
- Article: SUPPORTIVE CARE IN CANCER. 2012;20(9):2025-2032Johansson E; Larsen J; Schempp T; Jonsson L; Winterling J
- Article: SUPPORTIVE CARE IN CANCER. 2010;18(11):1377-1384Winterling J; Wasteson E; Arving C; Johansson B; Glimelius B; Nordin K
- Article: EUROPEAN JOURNAL OF CANCER CARE. 2009;18(6):585-593Winterling J; Sidenvall B; Glimelius B; Nordin K
- Article: PSYCHO-ONCOLOGY. 2008;17(2):190-198Winterling J; Glimelius B; Nordin K
- Article: SUPPORTIVE CARE IN CANCER. 2006;14(4):310-319Winterling J; Wasteson E; Sidenvall B; Sidenvall E; Glimelius B; Sjödén PO; Nordin K
- Article: CANCER NURSING. 2004;27(5):381-388Winterling J; Wasteson E; Glimelius B; Sjödén PO; Nordin K
- Show more
All other publications
- Preprint: PREPRINTS.ORG. 2025Kisch AM; Eriksson LV; O’Sullivan A; Shahriari A; Bergkvist K; Hagelin CL; Winterling J
- Conference publication: BONE MARROW TRANSPLANTATION. 2024;59:671Kisch AM; Eriksson L; O'Sullivan A; Bergkvist K; Hagelin CL; Winterling J
- Conference publication: QUALITY OF LIFE RESEARCH. 2024;33:S31-S32Sodergren S; Husson O; Rohde G; Hossain J; Abaza H; Alkan A; Al-Omari A; Ben Aharon I; Bentsen L; Chalk T; Guren MG; Ionnidis G; Ishiki H; Koehler M; Lidington E; Lugowska I; Krishnamurphy NM; McDonald F; Majorana A; Memos N; Otth M; Pappot H; Campdepadros MP; Petronovic D; Scheinemann K; Sikora-Koperska A; Stark D; Turhal NS; Winterling J; Yarom N; Janssen S; Darlington A-S
- Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S17Sodergren S; Husson O; Rohde G; Alkan A; Al Omari A; Ben-Aharon I; Guren M; Ioannidis G; Ishiki H; Koehler M; Krishnamurthy N; Majorana A; Memos N; Pappot H; Petranovic D; Richter D; Stark D; Turhal S; Winterling J; Darlington A-S
- Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S15-S16Sodergren S; Husson O; Rohde G; Alkan A; Al Omari A; Ben-Aharon I; Guren M; Ioannidis G; Ishiki H; Koehler M; Krishnamurthy N; Majorana A; Memos N; Pappot H; Petranovic D; Richter D; Stark D; Turhal S; Winterling J; Darlington A-S
- Conference publication: BONE MARROW TRANSPLANTATION. 2023;58(SUPP1):633-634O'Sullivan A; Winterling J; Holmberg K; Bergkvist K; Kisch AM; Lundh-Hagelin C
- Conference publication: BONE MARROW TRANSPLANTATION. 2023;58(SUPP1):632Hagelin CL; Winterling J; Kisch A; Holmberg K; O'Sullivan A; Bergkvist K
- Conference publication: BONE MARROW TRANSPLANTATION. 2022;57(SUPPL 1):420Kisch AM; Bergkvist K; Adalsteinsdottir S; Wendt C; Alvariza A; Winterling J
- Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1202Winterling J; Pahnke S; Hagglund H; Larfors G; Lennhof S; Kisch A
- Preprint: RESEARCH SQUARE. 2022Kisch AM; Bergkvist K; Adalsteinsdóttir S; Wendt C; Alvariza A; Winterling J
- Preprint: RESEARCH SQUARE. 2021Winterling J; Delilovic S; Dervish J; Gunnarsson M; Åhström M; Hasson H
- Conference publication: BONE MARROW TRANSPLANTATION. 2020;55(SUPPL 1):722-723Eriksson LV; Holmberg K; Bergkvist K; Hagelin CL; Winterling J
- Conference publication: BONE MARROW TRANSPLANTATION. 2020;55(SUPPL 1):715-716Kisch AM; Bergkvist K; Alvariza A; Winterling J
- Letter: HAEMATOLOGICA. 2020;105(6):e310-e314Boberg E; Kadri N; Winterling J; Davies LC; Bjorklund A; Msghina M; Iacobaeus E; Le Blanc K
- Conference publication: PSYCHO-ONCOLOGY. 2018;27:174Eriksson LV; Wennman-Larsen A; Bergkvist K; Ljungman P; Winterling J
- Conference publication: PSYCHO-ONCOLOGY. 2018;27:123Kisch A; Bergkvist K; Alvariza A; Winterling J
- Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S518Kotte M; Karlsson K; Winterling J
- Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S516-S517Winterling J; Wiklander M; Lampic C; Obol CM; Eriksson LE; Wettergren L
- Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S130Winterling J; Wiklander M; Lampic C; Obol CM; Eriksson LE; Wettergren L
- Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S260Winterling J; Johansson E; Wettergren L; Ljungman P; Alexanderson K
- Conference publication: PEDIATRIC BLOOD & CANCER. 2012;59(6):1131Doukkali EB; Winterling J; Eriksson LE; Lampic C; af Sandeberg M; Wettergren L
- Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S325Winterling J; Johansson E
- Show more
Grants
- Swedish Research Council1 January 2023 - 31 December 2026Background: The age standardised rate of yearly new cancer cases is 190/100 000 globally, by WHO. 30-40% of these will develop depression. There is currently no specific antidepressant treatment regime implemented in the cancer population. This is in spite of the specific needs given by concurrent cancer treatments, limited quality of life from the cancer per se and the often limited life expectancy from a cancer disease. A single dose of psilocybin combined with 3 hours of psychological support has shown rapid (within days) and long term (months or years) antidepressant effect in several small studies in different cancer populations. Large, well designed RCTs are still lacking, as is response predictors for treatment guidance. I am PI of the first RCT of psilocybin treament of depression in Sweden, expected to end randomisation in june 2022. CAPSI: 100 patients with cancer and depression will be randomised to psilocybin or active placebo (2:1) at 4 different regions in Sweden during 2024-2025. Primary end point is depressive symptoms 6 weeks post dose and follw up is 6 months. All subjects will undergo EEG and blood sampling, a subsample (n=50) will also undergo MEG and fMRI, and 25 of them also PET, in order to develop a EEG proxy response signature. Together with markers in blood we will develop a predictor model for psilocybin treatment response. All data will be used to motivate a phase three study with the same PICO and further development of the response markers.
Employments
- Affiliated to Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 2024-2027
Degrees and Education
- Docent, Nursing, Karolinska Institutet, 2023
